PinUp: “Crushing” Pharma Via Lawsuits, Amazon, and Somewhat Unnecessary FDA Guidance
Welcome to the December 12, 2017, issue of Pharma Industry News Update (aka PinUp). You would think by now pharma marketers would be well versed in the correct product name placement, size, prominence, and frequency in promotional labeling and advertising for prescription drugs. Obviously not because the FDA recently released guidance on the topic.
PinUp: FDA Guidance “Leaps” Ahead on 3D Printing & Digital, But Misses the Mark...
Welcome to the December 8, 2017, issue of Pharma Industry News Update (aka PinUp). Leaping Lizards! or Frogs! or Whatever! FDA seems to be leaping forward giving guidances to the drug and medical device industries regarding 3D printing and clinical decision software tools. But there's always someone left out. What about artificial intelligence? Hmmm...
PinUp: Mobile Apps Set to Disrupt How Clinical Trials are Run
Welcome to the December 5, 2017, issue of Pharma Industry News Update (aka PinUp). I just downloaded Apple's
PinUp: Medical Journals versus the Internet: Is the “Prior Publication” Battle Over?
Welcome to the November 21, 2017, issue of Pharma Industry News Update (aka PinUp). History has a way of repeating itself. This issue focuses on on peer-reviewed journals and the battle for timely and accurate publication of scientific/medical research results. The first skirmish of this battle occurred 50 years ago when the NIH distributed unpublished scientific papers via snail mail - the Internet and email were not widely available at the time. Then the modern Internet got involved in the 1990's and then again in 2013. Which is winning the battle?
PinUp: Digital Pills, Fat Tweets, and Chatbots
Welcome to the November 17, 2017, issue of Pharma Industry News Update (aka PinUp). FDA seems anxious to embrace digital technology not just in the realm of medical devices, but also for transforming ingestible medicines; i.e., pills. But the first
PinUp: The Masters to Whom Pharma CEOs Are Beholden!
Welcome to the November 14, 2017, issue of Pharma Industry News Update (aka PinUp). This issue focuses on pharma CEOs and to whom they are beholden. It's a well-known fact that pharma CEOs are beholding first to Wall Street. Their compensation is directly related to their companies' stock price. But these days, pharma CEOs are beholding to the president to the extent that we now have the
PinUp: Three Notable Failures: EpiPen, Allergan TV DTC, & FDA Enforcement
Welcome to the November 3, 2017, issue of Pharma Industry News Update (aka PinUp). There were reports of three
PinUp: Three Myths: FDA hinders pharma’s digital health efforts, “Just Say No to Drugs”...
Welcome to the October 31, 2017, issue of Pharma Industry News Update (aka PinUp). Some experts are 'heartbroken' that the pharmaceutical industry has not done more in the digital health arena and they blame it on belief in
PinUp: How to Get Away with Murder. Raise prices again & again, “educate” physicians,...
Welcome to the October 27, 2017, issue of Pharma Industry News Update (aka PinUp). Some drugs sell themselves, others require an army of
PinUp: Follow the Money: Patient Groups, Rebates, More New Drugs
Welcome to the October 24, 2017, issue of Pharma Industry News Update (aka PinUp). Pharma financial support of patient groups is nothing new, but when you learn that 93% of them receive pharma funding it's a shock. And it seems money buys influence. IMHO, it may be time for more transparency.
